Functional evidence implicating FOXL2 in non syndromic premature ovarian failure and in the regulation of the transcription factor OSR2

Paul Laissue ¹, Besma Lakhal ², Bérénice A Benayoun ¹, Aurélie Dipietromaria ¹, Rim Braham ³, Hatem Elghezal ², Pascal Philibert ⁴, Ali Saâd ², Charles Sultan ⁴, Marc Fellous ¹ and Reiner Veitia ^5*

¹ INSERM U567, Institut Cochin, Paris, France
² Department of Cytogenetics and Reproductive Biology, Farhat Hached University Teaching Hospital, Tunisia
³ Department of Endocrinology, Farhat Hached University Teaching Hospital, Tunisia
⁴ Hôpital Arnaud-de-Villeneuve and Service d'Hormonologie du Développement et de la Reproduction, France
⁵ Institut Cochin. INSERM U567, CNRS UMR 8104/ENS, France

^* To whom correspondence should be addressed. E-mail: reiner.veitia{at}inserm.fr.

Accepted 23 February 2009

Abstract

Background: FOXL2 encodes a forkhead transcription factor whose mutations are responsible for the Blepharophimosis-Ptosis-Epicanthus inversus Syndrome (BPES), involving craniofacial/palpebral abnormalities often associated with premature ovarian failure (POF).

Results: We describe a FOXL2 variant (p.Gly187Asp) in a case of POF without BPES. The subcellular localization of FOXL2-G187D was normal but its transactivation capacity tested on two reporter promoters, one of which should be relevant to the ovary, was significantly lower than that of normal FOXL2. However, FOXL2-G187D was able to strongly activate a reporter construct driven by the promoter of Osr2 (odd-skipped related 2 transcription factor), which we have suggested to be a crucial target of FOXL2 in the craniofacial region. This is compatible with the absence of BPES in our patient.

Conclusions: Our data provide evidence in favor of the implication of FOXL2 variants in non-syndromic POF and confirm the regulatory interaction between FOXL2 and OSR2 whose perturbation might contribute to the palpebral abnormalities observed in BPES patients.